BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22459525)

  • 1. The impact of chemotherapy-induced cognitive impairment on the psychosocial adjustment of patients with nonmetastatic colorectal cancer.
    Galica J; Rajacich D; Kane D; Pond GR
    Clin J Oncol Nurs; 2012 Apr; 16(2):163-9. PubMed ID: 22459525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of life stage on psychosocial adjustment in colorectal cancer patients.
    Nishigaki M; Kazuma K; Oya M; Ueno M; Arai M; Yamaguchi T; Muto T
    J Psychosoc Oncol; 2007; 25(4):71-87. PubMed ID: 18032266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature.
    Falleti MG; Sanfilippo A; Maruff P; Weih L; Phillips KA
    Brain Cogn; 2005 Oct; 59(1):60-70. PubMed ID: 15975700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive adverse effects of chemotherapy in breast cancer patients.
    Correa DD; Ahles TA
    Curr Opin Support Palliat Care; 2007 Apr; 1(1):57-62. PubMed ID: 18660726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between chemotherapy and cognitive impairments in a large cohort of patients with colorectal cancer.
    Du XL; Cai Y; Symanski E
    Int J Oncol; 2013 Jun; 42(6):2123-33. PubMed ID: 23563930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide.
    Jansen CE; Dodd MJ; Miaskowski CA; Dowling GA; Kramer J
    Psychooncology; 2008 Dec; 17(12):1189-95. PubMed ID: 18506671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive functions in long-term survivors of ovarian cancer.
    Correa DD; Zhou Q; Thaler HT; Maziarz M; Hurley K; Hensley ML
    Gynecol Oncol; 2010 Nov; 119(2):366-9. PubMed ID: 20630576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of cognitive deficits with elevated homocysteine levels in euthymic bipolar patients and its impact on psychosocial functioning: preliminary results.
    Dittmann S; Seemüller F; Schwarz MJ; Kleindienst N; Stampfer R; Zach J; Born C; Bernhard B; Fast K; Grunze H; Engel RR; Severus E
    Bipolar Disord; 2007; 9(1-2):63-70. PubMed ID: 17391351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meaning-making and psychological adjustment to cancer: development of an intervention and pilot results.
    Lee V; Cohen SR; Edgar L; Laizner AM; Gagnon AJ
    Oncol Nurs Forum; 2006 Nov; 33(2):291-302. PubMed ID: 16518445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychosocial adjustment in colorectal cancer patients undergoing chemotherapy or chemoradiotherapy.
    Alvarado-Aguilar S; Guerra-Cruz HG; Cupil-Rodríguez AL; Calderillo-Ruiz G; Oñate-Ocaña LF
    Cir Cir; 2011; 79(5):439-46. PubMed ID: 22385764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Women's perceptions of chemotherapy-induced cognitive side affects on work ability: a focus group study.
    Munir F; Burrows J; Yarker J; Kalawsky K; Bains M
    J Clin Nurs; 2010 May; 19(9-10):1362-70. PubMed ID: 20500346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy.
    Mehnert A; Scherwath A; Schirmer L; Schleimer B; Petersen C; Schulz-Kindermann F; Zander AR; Koch U
    Patient Educ Couns; 2007 Apr; 66(1):108-18. PubMed ID: 17320337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meaning-making intervention during breast or colorectal cancer treatment improves self-esteem, optimism, and self-efficacy.
    Lee V; Robin Cohen S; Edgar L; Laizner AM; Gagnon AJ
    Soc Sci Med; 2006 Jun; 62(12):3133-45. PubMed ID: 16413644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A meta-analysis of the effects of chemotherapy on cognition in patients with cancer.
    Hodgson KD; Hutchinson AD; Wilson CJ; Nettelbeck T
    Cancer Treat Rev; 2013 May; 39(3):297-304. PubMed ID: 23219452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of cognitive function associated with chemotherapy: a review of published studies and recommendations for future research.
    Vardy J; Rourke S; Tannock IF
    J Clin Oncol; 2007 Jun; 25(17):2455-63. PubMed ID: 17485710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of psychosocial adjustment in people with physical disease.
    Kocaman N; Kutlu Y; Ozkan M; Ozkan S
    J Clin Nurs; 2007 Mar; 16(3A):6-16. PubMed ID: 17518864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perceived control and involvement in self care in patients with colorectal cancer.
    Kidd L; Hubbard G; O'Carroll R; Kearney N
    J Clin Nurs; 2009 Aug; 18(16):2292-300. PubMed ID: 19583662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A meta-analysis of the sensitivity of various neuropsychological tests used to detect chemotherapy-induced cognitive impairment in patients with breast cancer.
    Jansen CE; Miaskowski CA; Dodd MJ; Dowling GA
    Oncol Nurs Forum; 2007 Sep; 34(5):997-1005. PubMed ID: 17878128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurocognitive effects of chemotherapy and endocrine therapies in the treatment of breast cancer: recent perspectives.
    Walker CH; Drew BA; Antoon JW; Kalueff AV; Beckman BS
    Cancer Invest; 2012 Feb; 30(2):135-48. PubMed ID: 22250588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life in patients with colorectal cancer 1 year after diagnosis compared with the general population: a population-based study.
    Arndt V; Merx H; Stegmaier C; Ziegler H; Brenner H
    J Clin Oncol; 2004 Dec; 22(23):4829-36. PubMed ID: 15570086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.